Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial - Mateos, M V; Richardson, P G; Schlag, R (J Clin Oncol, 2010)
et al.